In depth exploration of IL-3 R α: structure, function, and significance in diseases
Author: Senior Product Manager of UA Views：368 
In the complex network of cytokine regulation, the interleukin-3 receptor alpha chain (IL-3 R α) plays an indispensable role as a key component. IL-3 R α not only participates in the fine regulation of hematopoietic processes, but also plays an important role in immune responses and the occurrence and development of various diseases. In depth research on IL-3 R α can help us understand the signal exchange mechanism between cells under normal physiological conditions, and provide key targets and theoretical basis for the development of treatment strategies for related diseases.
- Recent Advances
- Product Information
Recent Advances
In-depth Exploration of IL-3 Rα: Structure, Function, and Significance in Diseases
Introduction
In the complex network regulated by cytokines, interleukin-3 receptor alpha chain (IL-3 Rα) plays an indispensable role as a key component. IL-3 Rα not only participates in the precise regulation of hematopoiesis but also plays an important role in immune responses and the occurrence and development of various diseases. In-depth research on IL-3 Rα helps us understand the mechanism of intercellular signal communication under normal physiological conditions and provides key targets and theoretical basis for the development of therapeutic strategies for related diseases.
Basic Structure of IL-3 Rα
IL-3 Rα, also known as CD123 (cluster of differentiation 123), is a glycoprotein with a molecular weight of approximately 70 kD, belonging to the hematopoietic cytokine receptor superfamily. Its encoding gene is located in the Xp22.3 region of the X chromosome and the Yp13.3 region of the Y chromosome. This localization on sex chromosomes suggests that its function may have gender-related differences. The gene is highly conserved in the evolutionary process and has homologous genes in various organisms such as chimpanzees, dogs, cattle, mice, and rats, which further illustrates the importance and fundamentality of its function in organisms.
IL-3 Rα, as the interleukin-3 specific subunit in heterodimeric cytokine receptors, constitutes the IL-3 receptor together with the ligand-specific alpha subunit and the signal transduction beta subunit. Among them, the beta subunit is shared by interleukin-3 (IL-3), colony-stimulating factor 2 (CSF2, also known as GM-CSF), and interleukin-5 (IL-5) receptors. It cannot directly bind to IL-3 but plays a key role in the binding process between IL-3 and IL-3 Rα, and the effective binding of IL-3 Rα to IL-3 depends on the presence of the beta subunit. Meanwhile, the IL-3 Rα gene and the gene encoding colony-stimulating factor 2 receptor alpha chain (CSF2RA) form a cytokine receptor gene cluster in the X-Y pseudoautosomal region, and this close genetic association may imply some synergistic or mutual influence relationship in their functions.
Functional Mechanism of IL-3 Rα
Hematopoietic Regulation Function
IL-3 is a pleiotropic cytokine that plays a core role in hematopoietic regulation, and IL-3 Rα is the key starting point for IL-3 to exert its function. IL-3 Rα is mainly expressed on the surface of early hematopoietic cells such as hematopoietic stem cells, myeloid progenitor cells, and lymphoid progenitor cells. When IL-3 binds to IL-3 Rα, the receptor undergoes dimerization or oligomerization, thereby activating a series of intracellular signal transduction pathways.
By activating the JAK-STAT5 signaling pathway, the IL-3/IL-3 Rα complex can regulate DNA synthesis, cell cycle progression, and promote cell proliferation. At the same time, the complex can also induce the expression of cytokine-inducible SH2-containing protein (CIS), pim-1 (a serine/threonine kinase whose gene has carcinogenic potential), oncostatin M (OSM), and c-fos genes. These gene products play important regulatory roles in cell growth, differentiation, and survival. In addition, in hematopoietic cells, IL-3 synergizes with the distal part of the IL-3 Rβ chain to activate the mitogen-activated kinase (MAPK) pathway, further promoting the proliferation and differentiation of hematopoietic cells. IL-3 can induce the proliferation and maturation of multipotent hematopoietic progenitor cells, bone marrow cells, eosinophils, basophils, erythroid cells, and megakaryocytic cells through IL-3 Rα, which is of great significance for maintaining the stability and dynamic balance of the hematopoietic system.
Immunoregulatory Function
The signaling pathway mediated by IL-3 Rα also plays an important role in immune regulation. By binding to IL-3 Rα, IL-3 can enhance the cytotoxic activity, bactericidal activity, and antitumor activity of macrophages, improving the body's innate immune function. In terms of adaptive immunity, IL-3 can promote the proliferation of peripheral blood T cells. In the presence of IL-2, it can synergistically promote the proliferation and differentiation of activated B cells, induce activated B cells to secrete IgG, and promote the proliferation and differentiation of B cell precursors in leukemia patients. At the same time, IL-3 can directly stimulate cells to release inflammatory regulatory factors such as histamine, leukotrienes, or platelet-activating factor, playing a role in the initiation and regulation of inflammatory responses.
IL-3 Rα-related Signaling Pathways
JAK-STAT5 Signaling Pathway
As mentioned earlier, the binding of IL-3 to IL-3 Rα causes a conformational change in the receptor, recruiting and activating Janus kinase 2 (JAK2). Activated JAK2 phosphorylates the tyrosine residues of the IL-3 Rα and IL-3 Rβ subunits, providing binding sites for STAT5. After being recruited to the receptor complex, STAT5 is phosphorylated, and the phosphorylated STAT5 forms a dimer and translocates into the nucleus, binds to specific DNA sequences in the promoter region of target genes, regulates gene transcription, and promotes the expression of genes related to cell proliferation, survival, and differentiation.
MAPK Signaling Pathway
IL-3 stimulation can also activate Ras protein, thereby activating the mitogen-activated protein kinase (MAPK) signaling pathway through the Raf-MEK-ERK cascade reaction. The activation of this pathway plays an important role in regulating various cellular processes such as cell proliferation, differentiation, survival, and migration. In hematopoietic cells, the activation of the MAPK pathway is closely related to the promotion of hematopoietic progenitor cell proliferation and differentiation by IL-3. At the same time, the MAPK pathway can interact with other signaling pathways to jointly regulate the cellular response to IL-3 stimulation.
NF-κB Signaling Pathway
Tumor necrosis factor receptor-associated factor 6 (TRAF6) can be recruited to the IL-3 Rβ subunit, thereby activating the NF-κB signaling pathway. Activated NF-κB translocates into the nucleus and regulates the expression of a series of genes related to inflammation, immune response, and cell survival. In inflammatory responses, IL-3 activates the NF-κB signaling pathway through IL-3 Rα, promoting the expression of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and amplifying the inflammatory response.
Role of IL-3 Rα in Diseases
Hematological Diseases
In acute myeloid leukemia (AML), IL-3 Rα (CD123) is highly expressed, and compared with normal hematopoietic stem cells, AML cells are more sensitive to IL-3. The continuous activation of the IL-3/IL-3 Rα signaling pathway can promote the proliferation, survival, and inhibit the apoptosis of AML cells, enabling AML cells to gain a growth advantage. Therefore, IL-3 Rα has become a highly potential target for AML immunotherapy. Currently, immunotherapeutic strategies targeting IL-3 Rα, such as antibody-drug conjugates (ADCs) and CAR-T cell therapy, are being explored in clinical trials, aiming to specifically kill AML cells by targeting IL-3 Rα while reducing damage to normal hematopoietic stem cells.
In some hematopoietic dysfunction diseases, such as aplastic anemia, abnormalities in IL-3 Rα and its mediated signaling pathways may lead to the blockage of hematopoietic stem cell proliferation and differentiation, resulting in bone marrow hematopoietic failure and peripheral blood cell reduction. In-depth study of the molecular mechanism of IL-3 Rα in these diseases is helpful for the development of new therapeutic methods to restore hematopoietic function.
Inflammatory Diseases
In inflammatory diseases such as sepsis, the IL-3/IL-3 Rα axis plays an important role. IL-3 can amplify inflammatory signals, trigger cytokine storms, and lead to multiple organ dysfunction or even failure. Studies have found that lipopolysaccharide (LPS) stimulation can reduce the expression of RNFT2 (a ring finger transmembrane domain-containing protein 2, also known as TMEM118). As an E3 ubiquitin ligase, RNFT2 can ubiquitinate IL-3 Rα and promote its degradation in the proteasome, thereby negatively regulating IL-3-dependent cellular responses. After LPS stimulation reduces RNFT2 expression, the half-life of IL-3 Rα is prolonged, cell sensitivity to IL-3 is enhanced, and inflammatory signals are further amplified. In mouse sepsis models, IL-3 neutralizing antibodies can reduce LPS-induced lung injury, suggesting that IL-3 Rα may become a potential target for sepsis treatment.
In neurological inflammatory diseases such as ischemic stroke, IL-3 derived from astrocytes can activate IL-3 Rα in microglia. However, under pathological conditions such as ischemia-reperfusion injury (I/R) and oxygen-glucose deprivation and reoxygenation (OGD/Re), the protein levels of astrocyte IL-3 and microglial IL-3 Rα are significantly decreased, accompanied by pro-inflammatory activation of A1-type astrocytes and M1-type microglia, mediating nerve cell damage. Studies have shown that exogenous supplementation of IL-3 or the use of the VEGFR antagonist axitinib can re-establish the interaction of IL-3/IL-3 Rα, improve the lipid metabolism level of microglia, restore the phagocytic function of microglia, reduce pro-inflammatory activation, and promote brain recovery from I/R injury. This suggests that the IL-3/IL-3 Rα axis plays an important role in the pathophysiological process of neurological inflammatory diseases and may become a therapeutic target.
Conclusion and Outlook
As a key subunit of the IL-3 receptor, IL-3 Rα plays a core role in physiological processes such as hematopoietic regulation and immune regulation. Abnormalities in its mediated signaling pathways are closely related to the occurrence and development of various diseases. Currently, research on IL-3 Rα in disease treatment has made certain progress, especially in the field of immunotherapy for hematological tumors. However, there are still many problems to be solved, such as the precise regulatory mechanism of IL-3 Rα in different diseases, how to improve the specificity and effectiveness of IL-3 Rα-targeted therapeutic strategies, and reduce side effects. In the future, with the deepening of research, we are expected to further reveal the biological functions and mechanisms of action of IL-3 Rα, providing more precise and effective therapeutic methods for the treatment of related diseases.
This article is reviewed and published by the technical expert team of UA
Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.
Purchase recombinant protein, choose Nanjing UA-Bio
UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.
Target proteins | membrane proteins | cytokines | enzymes | viral antigens | protein customization
Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161
Product Information
Link：
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy 
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
Business license (three certificates in one) Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.
